DOI: https://doi.org/10.22141/2224-1485.6.62.2018.153933

Proceedings of the International symposium organized by PO “Ukrainian Antihypertensive Society” and the International Society of Vessels Health and Aging “Evaluating the function and structure of arteries — clinical aspects” (Odesa, May 30–31 — June 1)

No authors .

Abstract


No abstract


References


Akoudad S., Wolters F.J., Viswanathan A. et al. Association of Cerebral Microbleeds With Cognitive Decline and Dementia // JAMA Neurol. — 2016. — 73(8). — Р. 934-943.

Benjamin P., Lawrence A.J., Lambert C. et al. Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease // Neuroimage Clin. — 2014. — 4. — Р. 828-837.

Choi S.Y., Park H.E., Seo H., Kim M., Cho S.H., Oh B.H. Arterial stiffness using cardioankle vascular index reflects cerebral small vessel disease in healthy young and middle aged subjects // J. Atheroscler. Thromb. — 2013. — 20(2). — Р. 178-185.

Das R.R., Seshadri S., Beiser A.S. et al. Prevalence and correlates of silent cerebral infarcts in the Framingham ofspring study // Stroke. — 2008. — 39. — Р. 2929-35.

Debette S., Beiser A., DeCarli C. et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study // Stroke. — 2010. — 41. — Р. 600-6.

Desmond D.W., Moroney J.T., Paik M.C. et al. Frequency and clinical determinants of dementia after ischemic stroke // Neurology. — 2000. — 54. — Р. 1124-31.

Emdin C.A., Rothwell P.M., Salimi-Khorshidi G. et al. Blood pressure and risk of vascular dementia: evidence from 4.3 million adults and a cohort study of TIA and stroke // Stroke. — 2016. — 47. —Р. 1429-1435.

Feldman H.H., Doody R.S., Kivipelto M. et al. LEADe Investigators. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe // Neurology. — 2010. — 74. — Р. 956-964.

Forette F., Seux M-L., Staessen E.A. et al. The prevention of dementia with antihypertensive treatment. New evidence from Syst-Eur Study // Arch. Intern. Med. — 2002. — 152. — Р. 2046-2052.

Gorelick P.B., Scuteri A., Black S.E. et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association // Stroke. — 2011. — 42. — Р. 2672-2713.

Gottesman R.F., Hillis A.E. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke // Lancet Neurol. — 2010. — 9. — Р. 895-905.

Hörder H., Johansson L., Guo X., Grimby G., Kern S., Östling S. et al. Midlife cardiovascular fitness and dementia: A 44-year longitudinal population study in women // Neurology. — 2018. — 10. — 90(15). — Р. 1298-1305.

Hughes T.M., Wagenknecht L.E., Craft S. et al. Arterial stiffness and dementia pathology // Neurology. — 2018. — 90(14). — Р. 1248-1256.

Joly L. Arterial stiffness and cognitive function. Geriatr // Psychol. Neuropsychiatr. Vieil. — 2017. — 1. — 15(1). — Р. 83-88.

Komulainen P., Kivipelto M., Lakka T.A., Hassinen M., Helkala E.L., Patja K., Nissinen A., Rauramaa R. Carotid intima-media thickness and cognitive function in elderly women: a population-based study // Neuroepidemiology. — 2007. — 28. — Р. 207-213.

Kuller L.H., Lopez O.L., Newman A. et al. Risk factors for dementia in the cardiovascular Health Cognition Study // Neuroepidemiology. — 2003. — 22. — Р. 13-22.

Launer L.J., Ross G.W., Petrovitch H., Masaki K., Fo­ley D., White L.R., Havlik R.J. Midlife blood pressure and dementia: the Honolulu-Asia aging study // Neurobiol Aging. — 2000. — 21. — Р. 49-55.

Leys D., Henon H., Mackowiak-Cordoliani M.A., Pasquier F. Poststroke dementia // Lancet Neurol. — 2005. — 4. — Р. 752-759.

Li X., Lyu P., Re Y., An J., Dong Y. Arterial stiffness and cognitive impairment // Journal of the Neurological Sciences. — 2017. — 380. — Р. 1-10.

Lim S.L., Gao Q., Nyunt M.S. et al. Vascular health indices and cognitive domain function: Singapore longitudinal ageing studies // J. Alzheimers Dis. — 2016. — 50. — 1. — Р. 27-40.

Liu-Ambrose T., Best J.R., Davis J.C., Eng J.J., Lee P.E., Jacova C., Boyd L.A., Brasher P.M., Munkacsy M., Cheung W., Hsiung G.R. Aerobic exercise and vascular cognitive impairment: A randomized controlled trial // Neurology. — 2016. — 87(20). — Р. 2082-2090.

Longstreth W.T. Jr, Dulberg C., Manolio T.A. et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study // Stroke. — 2002. — 33. — Р. 2376-82.

Longstreth W.T. Jr, Arnold A.M., Beauchamp N.J. Jr et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study // Stroke. — 2005. — 36. — Р. 56-61.

Manly J.J., Bell-McGinty S., Tang M.X. et al. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community // Arch. Neurol. — 2005. — 62. — Р. 1739-46.

Matthews F.E., Arthur A., Barnes L.E. et al. on behalf of the Medical Research Council Cognitive Function and Ageing Collaboration. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II // Lancet. — 2013. — 382. — Р. 1405-1412.

McGuinness B., Todd S., Passmore P., Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia // Cochrane Database Syst. Rev. — 2009. — 4. — CD004034.

Merino J.G., Hachinski V. What is vascular cognitive impairment? // The Behavioral and Cognitive Neurology of Stroke / ed. Olivier Godefroy. — Cambridge University Press, 2013. — P. 1-8.

Mielke M.M., Zandi P.P., Sjogren M. et al. High total cholesterol levels in late life associated with a reduced risk of dementia // Neurology. — 2005. — 64. — Р. 1689-1695.

Moll van Charante E.P., Richard E., Eurelings L.S., van Dalen J.W., Ligthart S.A., van Bussel E.F. et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial // Lancet. — 2016. — 388. — Р. 797-805.

Morović S., Jurasić M.J., Martinić Popović I., Serić V., Lisak M., Demarin V. Vascular characteristics of patients with dementia // J. Neurol. Sci. — 2009. — 283. — Р. 41-43.

Muller M., Grobbee D.E., Aleman A., Bots M., van der Schouw Y.T. Cardiovascular disease and cognitive performance in middle-aged and elderly men // Atherosclerosis. — 2007. — 190. — Р. 143-149.

Ninomiya T., Ohara T., Hirakawa Y., Yoshida D., Doi Y., Hata J., Kanba S., Iwaki T., Kiyohara Y. Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study // Hypertension. — 2011. — 58. — Р. 22-28.

Norton S., Matthews F.E., Barnes D.E., Yaffe K., Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population based data // Lancet Neurol. — 2014. — 13. — Р. 788-794.

Pase M.P., Beiser A., Himali J.J. et al. Aortic Stiffness and the Risk of Incident Mild Cognitive Impairment and Dementia // Stroke. — 2016. — 47(9). — Р. 2256-2261.

Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis // Lancet Neurol. — 2009. — 8. — Р. 1006-18.

Peters R., Beckett N., Forette F., Tuomilehto J., Clarke R., Ritchie C. et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial // Lancet Neurol. — 2008. — 7. — Р. 683-689.

Peters R. Investigation of Antihypertensive Class Effects on Dementia and Cognitive Decline: A Collaborative Meta-Analysis of Participant Data. Alzheimer’s Association International Conference (AAIC) 2018. — Abstract 25142. — Presented July 24, 2018.

Poels M.M.F., Van Oijen M., Mattace-Raso F.U.S., Hofman A., Koudstaal P.J., Witteman J.C.M. et al. Arterial stiffness, cognitive decline, and risk of dementia: The Rotterdam study // Stroke. — 2007. — 38. — Р. 888-892.

Pohjasvaara T., Erkinjuntti T., Vataja R., Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Me-mory Study (SAM) cohort // Stroke. — 1997. — 28. — Р. 785-92.

Prins N., von Dijk M.J., der Hejer T. et al. Cerebral white matter leisure and the risk of dementia // Arch. Neurol. — 2004. — 61. — Р. 1531-1534.

Qiu C., Winblad B., Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia // Lancet Neurol. — 2005. — 4. — Р. 487-499.

Reitz C., Tang M.X., Luchsinger J., Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia // Arch. Neurol. — 2004. — 61. — Р. 705-714.

Sachdev P.S., Chen X., Brodaty H. et al. The determinants and longitudinal course of post-stroke mild cognitive impairment // J. Int. Neuropsychol. Soc. — 2009. — 15. — Р. 915-23.

Satizabal C.L., Beiser A.S., Chouraki V. et al. Incidence of Dementia over Three Decades. in the Framingham Heart Study // N. Engl. J. Med. — 2016. — 374. — Р. 523-532.

Scarmeas N., Stern Y., Mayeux R., Manly J.J.,

Schupf N., Luchsinger J.A. Mediterranean diet and mild cognitive impairment // Arch. Neurol. — 2009. — 66. — Р. 216-225.

Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons // Neurology. — 2007. — 69. — Р. 2197-204.

Silvestrini M., Gobbi B., Pasqualetti P., Bartolini M., Baruffaldi R., Lanciotti C., Cerqua R., Altamura C., Provinciali L., Vernieri F. Carotid atherosclerosis and cognitive decline in patients with Alzheimer’s disease // Neurobiol. Aging. — 2009. — 30. — Р. 1177-1183.

Solomon A., Kanstareholt I., Ngandu T. et al. Serum total cholesterol, statins and cognition in non-demented elderly // Neurobiol. Aging. — 2009. — 30. — Р. 1006-1009.

Solomon A., Kivipelto M., Wolozin B., Zhou J., Whitmer R.A. Midlife serum cholesterol and increased risk of Alzhei-mer’s and vascular dementia three decades later // Dement. Geriatr.

Cogn. Disord. — 2009. — 28. — Р. 75-80.

Sujyoti C., Malabendu J., Kalipada P. Aspirin induces Lysosomal biogenesis and attenuates Amyloid plaque pathology in a mouse model of Alzheimer's disease via PPARα // Journal of Neuroscience. — 2018. — 0054-18. DOI: 10.1523/JNEUROSCI.0054-18.2018.

Teodorczuk A., Firbank M.J., Pantoni L. et al. Relationship between baseline whitematter changes and development of late-life depressive symptoms: 3-year results from the LADIS study // Psychol. Med. — 2010. — 40(4). — Р. 603-610.

Trompet S., van Vliet P., de Craen A.J. et al. Pravastatin and cognitive function in the elderly: results of the PROSPER study // J. Neurol. — 2010. — 257. — Р. 85-90.

Tsoi K. et al. Combination Therapy Showed No Additio­nal Benefit over Monotherapy for Alzheimer’s Disease: A Network Meta-Analysis of 76 Randomized Controlled Trials. Alzheimer’s Association International Conference (AAIC) 2018. — Abstracts 20352, presented July 25, 2018.

van Middelaar T., van Vught L.A., van Gool W.A. et al. Blood pressure-lowering interventions to prevent dementia: a systematic review and meta-analysis // J. Hypertens. — 2018. — 36. — Р. 1780-1787.

van Sloten T.T., Protogerou A.D., Henry R.M., Schram M.T., Launer L.J., Stehouwer C.D. Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: a systematic review and meta-analysis // Neurosci., Biobehav. Rev. — 2015. — 53. — Р. 121-130.

Verdelho A., Madureira S., Ferro J.M. et al. LADIS Study. Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study // Stroke. — 2012. — 43(12). — Р. 3331-3335.

Vermeer S.E., Prins N.D., den Heijer T. et al. Silent brain infarcts and the risk of dementia and cognitive decline // N. Engl. J. Med. — 2003. — 348. — Р. 1215-22.

Vermeer S.E., Longstreth W.T. Jr, Koudstaal P.J. Silent brain infarcts: a systematic review // Lancet Neurol. — 2007. — 6. — Р. 611-19.

Waldstein S.R., Rice S.C., Thayer J.F., Najjar S.S., Scuteri A., Zonderman A.B. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging // Hypertension. — 2008. — 51. — Р. 99-104.

Williams P.S., Rands G., Orrel M., Spector A. Aspirin for vascular dementia // Cochrane Database Syst. Rev. — 2000. — CD001296.

Williamson J. and the SPRINT Research Group. A Randomized Trial of Intensive Versus Standard Systolic Blood Pressure Control and the Risk of Mild Cognitive Impairment and Dementia: Results from SPRINT MIND. Alzheimer’s Association International Conference (AAIC) 2018. Abstracts 27525 and 27526, presented July 25, 2018.




Copyright (c) 2019 HYPERTENSION

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта